Richard J Ulevitch Net Worth & Insider Trades

Richard J Ulevitch - Director, Phaserx, Inc

As of June 3, 2016

What is Richard J Ulevitch's Net Worth?

The current estimated net worth of Phaserx, Inc's Director, Richard J Ulevitch, is estimated to be about $93.62K . Richard J Ulevitch owns about 35,552 units of Phaserx, Inc common stock. Recently at Phaserx, Inc, Richard J Ulevitch has sold an estimated value of $4.56K worth.

What is Richard J Ulevitch's Past Insider Trading?

Richard J Ulevitch's largest purchase order was 100,000 units , worth over $500K on May 23, 2016. Richard J Ulevitch's largest sale order was 455,777 units , worth over $4.56K on May 23, 2016. In total, Richard J Ulevitch has made about 2 transactions recently at Phaserx, Inc. Richard J Ulevitch usually trades in June and May, with the busiest year in 2016.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Richard J Ulevitch

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Richard J Ulevitch's' Mailing Address?

  • Mailing address is 200 Sand Hill Road Suite 110 Menlo Park CA 94025 CA

What are Phaserx, Inc's Past Insider Trades?

Phaserx, Inc's most recent insider trade came on May 25, 2016 by Steven Gillis, Arch Venture Fund Vii Lp, Arch Venture Partners Vii Lp, Arch Venture Partners Vii Llc, Robert Nelsen, Clinton Bybee and Keith Crandell who sold 680,059 units worth $6.8K . In the years Phaserx, Inc was active, insiders at Phaserx, Inc have sold an estimated value of $16.52K and bought an estimated value of $11.5M worth of shares. Insider trading is most common in May, with the busiest year in 2016. The most active traders at the company are Brian Atwood, Director,  Gordon Brandt, Chief Medical Officer,  and John Schmidt Jr, Director .

PHASERX, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...